Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tsugumi Oda"'
Autor:
Chika Omoto, Katsumi Shigemura, Koichi Kitagawa, Hiroki Saito, Hak Hotta, Tsugumi Oda, Toshiro Shirakawa, Takane Katayama, Ayame Araki
Publikováno v:
Viral immunology. 30(3)
We previously generated an oral hepatitis C virus (HCV) vaccine using Bifidobacterium displaying the HCV nonstructural protein 3 (NS3) polypeptide. NS3-specific cellular immunity is important for viral clearance and recovery from HCV infection. In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03c02ae7685489584e9528d5ebcda84c
https://pubmed.ncbi.nlm.nih.gov/28112593
https://pubmed.ncbi.nlm.nih.gov/28112593
Autor:
Koichi Kitagawa, Katsumi Shigemura, Ayame Araki, Toshiro Shirakawa, Yoshiko Hashii, Takane Katayama, Masato Fujisawa, Tsugumi Oda, Hiroki Saito, Reina Gonoi
Publikováno v:
Cancer immunology, immunotherapy : CII. 66(6)
Several types of vaccine-delivering tumor-associated antigens (TAAs) have been developed in basic and clinical research. Wilms' tumor 1 (WT1), identified as a gene responsible for pediatric renal neoplasm, is one of the most promising TAA for cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32cdd6aa2a4d9e728f8d40e18e82c432
https://pubmed.ncbi.nlm.nih.gov/28299466
https://pubmed.ncbi.nlm.nih.gov/28299466
Autor:
Takane Katayama, Tsugumi Oda, Hiroki Saito, Reina Gonoi, Koichi Kitagawa, Yoshiko Hashii, Keiichi Ozono, Toshiro Shirakawa, Ayame Araki
Publikováno v:
Molecular Therapy. 24:S157
INTRODUCTION: The Wilms’ Tumor 1 gene (WT1), firstly reported as a gene responsible for pediatric renal cancer, is highly expressed in leukemia and various types of solid tumors. Therefore, WT1 gene products are considered as ideal targets for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da55f59df81ae0a6097c33c47a267ecd
https://doi.org/10.1016/s1525-0016(16)33204-x
https://doi.org/10.1016/s1525-0016(16)33204-x
Autor:
Hiroki Ishikawa, Hak Hotta, Koichi Kitagawa, Hiroki Saito, Yoichi Matsuura, Kouske Shimamoto, Naoya Morishita, Tsugumi Oda, Toshiro Shirakawa, Norihisa Nishida
Publikováno v:
Molecular Therapy. 23:S259
INTRODUCTION: Hepatitis C virus (HCV) is a major cause of chronic liver diseases, such as liver cirrhosis and hepatocellular carcinoma. The efficacy of the standard-of-care including interferon-α and ribavirin for chronic HCV infection is limited, e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ec51832faa3218a90da8ff388ad3e3
https://doi.org/10.1016/s1525-0016(16)34259-9
https://doi.org/10.1016/s1525-0016(16)34259-9